221 related articles for article (PubMed ID: 32129438)
1. De-escalation of Empiric Antibiotics Following Negative Cultures in Hospitalized Patients With Pneumonia: Rates and Outcomes.
Deshpande A; Richter SS; Haessler S; Lindenauer PK; Yu PC; Zilberberg MD; Imrey PB; Higgins T; Rothberg MB
Clin Infect Dis; 2021 Apr; 72(8):1314-1322. PubMed ID: 32129438
[TBL] [Abstract][Full Text] [Related]
2. Outcomes Associated With De-escalating Therapy for Methicillin-Resistant Staphylococcus aureus in Culture-Negative Nosocomial Pneumonia.
Cowley MC; Ritchie DJ; Hampton N; Kollef MH; Micek ST
Chest; 2019 Jan; 155(1):53-59. PubMed ID: 30621854
[TBL] [Abstract][Full Text] [Related]
3. The Daniel K. Inouye College of Pharmacy Scripts: The Effects of Vancomycin Use and De-escalation in Patients Hospitalized with Pneumonia.
You AS; Fukunaga BT; Hanlon AL; Lozano AJ; Goo RA
Hawaii J Med Public Health; 2018 Oct; 77(10):261-267. PubMed ID: 30324005
[TBL] [Abstract][Full Text] [Related]
4. Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.
Liu P; Ohl C; Johnson J; Williamson J; Beardsley J; Luther V
BMC Infect Dis; 2016 Dec; 16(1):751. PubMed ID: 27955625
[TBL] [Abstract][Full Text] [Related]
5. A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia.
Boyce JM; Pop OF; Abreu-Lanfranco O; Hung WY; Fisher A; Karjoo A; Thompson B; Protopapas Z
Antimicrob Agents Chemother; 2013 Mar; 57(3):1163-8. PubMed ID: 23254432
[TBL] [Abstract][Full Text] [Related]
6. Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia.
Schlueter M; James C; Dominguez A; Tsu L; Seymann G
Infection; 2010 Oct; 38(5):357-62. PubMed ID: 20652354
[TBL] [Abstract][Full Text] [Related]
7. Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial.
Kim JW; Chung J; Choi SH; Jang HJ; Hong SB; Lim CM; Koh Y
Crit Care; 2012 Feb; 16(1):R28. PubMed ID: 22336530
[TBL] [Abstract][Full Text] [Related]
8. Safety of De-Escalating Empiric Antimicrobial Agents in Trauma Patients with Indigenous Oral Flora Ventilator-Associated Pneumonia.
Kaylor DM; Caminiti N; Harbrecht B; McPheeters C; Scherrer LA
Surg Infect (Larchmt); 2022 Aug; 23(6):597-603. PubMed ID: 35917387
[No Abstract] [Full Text] [Related]
9. Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP).
Deshpande A; Walker R; Schulte R; Pallotta AM; Tereshchenko LG; Hu B; Kadri SS; Klompas M; Rothberg MB
Trials; 2023 Sep; 24(1):595. PubMed ID: 37716990
[TBL] [Abstract][Full Text] [Related]
10. Simulated Adoption of 2019 Community-Acquired Pneumonia Guidelines Across 114 Veterans Affairs Medical Centers: Estimated Impact on Culturing and Antibiotic Selection in Hospitalized Patients.
Christensen MA; Nevers M; Ying J; Haroldsen C; Stevens V; Jones MM; Yarbrough PM; Goetz MB; Restrepo MI; Madaras-Kelly K; Samore MH; Jones BE
Clin Infect Dis; 2021 Jan; 72(Suppl 1):S59-S67. PubMed ID: 33512530
[TBL] [Abstract][Full Text] [Related]
11. Impact of a Pharmacist-driven Methicillin-resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Protocol on the De-escalation of Empiric Vancomycin in Patients with Pneumonia in a Rural Healthcare Setting.
Dadzie P; Dietrich T; Ashurst J
Cureus; 2019 Dec; 11(12):e6378. PubMed ID: 31938656
[TBL] [Abstract][Full Text] [Related]
12. Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial.
Gohil SK; Septimus E; Kleinman K; Varma N; Avery TR; Heim L; Rahm R; Cooper WS; Cooper M; McLean LE; Nickolay NG; Weinstein RA; Burgess LH; Coady MH; Rosen E; Sljivo S; Sands KE; Moody J; Vigeant J; Rashid S; Gilbert RF; Smith KN; Carver B; Poland RE; Hickok J; Sturdevant SG; Calderwood MS; Weiland A; Kubiak DW; Reddy S; Neuhauser MM; Srinivasan A; Jernigan JA; Hayden MK; Gowda A; Eibensteiner K; Wolf R; Perlin JB; Platt R; Huang SS
JAMA; 2024 Jun; 331(23):2007-2017. PubMed ID: 38639729
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal Urinary Antigen Testing in United States Hospitals: A Missed Opportunity for Antimicrobial Stewardship.
Schimmel JJ; Haessler S; Imrey P; Lindenauer PK; Richter SS; Yu PC; Rothberg MB
Clin Infect Dis; 2020 Sep; 71(6):1427-1434. PubMed ID: 31587039
[TBL] [Abstract][Full Text] [Related]
14. MRSA nasal swab PCR to de-escalate antibiotics in the emergency department.
Sindelar MA; Zepeski AE; Lawler BJ; Johnston SD; Faine BA
Am J Emerg Med; 2022 May; 55():133-137. PubMed ID: 35313228
[TBL] [Abstract][Full Text] [Related]
15. Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers.
Jones BE; Brown KA; Jones MM; Huttner BD; Greene T; Sauer BC; Madaras-Kelly K; Rubin MA; Bidwell Goetz M; Samore MH
Infect Control Hosp Epidemiol; 2017 Aug; 38(8):937-944. PubMed ID: 28633678
[TBL] [Abstract][Full Text] [Related]
16. Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.
Jones BE; Ying J; Stevens V; Haroldsen C; He T; Nevers M; Christensen MA; Nelson RE; Stoddard GJ; Sauer BC; Yarbrough PM; Jones MM; Goetz MB; Greene T; Samore MH
JAMA Intern Med; 2020 Apr; 180(4):552-560. PubMed ID: 32065604
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use.
Rhee C; Kadri SS; Dekker JP; Danner RL; Chen HC; Fram D; Zhang F; Wang R; Klompas M;
JAMA Netw Open; 2020 Apr; 3(4):e202899. PubMed ID: 32297949
[TBL] [Abstract][Full Text] [Related]
18. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study.
Alvarez-Lerma F; Alvarez B; Luque P; Ruiz F; Dominguez-Roldan JM; Quintana E; Sanz-Rodriguez C;
Crit Care; 2006; 10(3):R78. PubMed ID: 16704742
[TBL] [Abstract][Full Text] [Related]
19. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
20. De-escalation therapy in ventilator-associated pneumonia.
Niederman MS
Curr Opin Crit Care; 2006 Oct; 12(5):452-7. PubMed ID: 16943725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
